# Gastrointestinal Postoperative Early Enteral Nutrition: Immuno-enhanced Versus Standard Early Enteral Nutrition

> **NCT01778166** · PHASE4 · UNKNOWN · sponsor: **Jinling Hospital, China** · enrollment: 200 (estimated)

## Conditions studied

- Gastrointestinal Malignant

## Interventions

- **DRUG:** Immuno-enhanced
- **DRUG:** Standard early enteral nutrition

## Key facts

- **NCT ID:** NCT01778166
- **Lead sponsor:** Jinling Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2014-02
- **Final completion:** 2014-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01778166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01778166, "Gastrointestinal Postoperative Early Enteral Nutrition: Immuno-enhanced Versus Standard Early Enteral Nutrition". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01778166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*